MoonLake Immunotherapeutics
MLTX | NASDAQ
$12.80
+$0.25 (+1.99%)
Sep 22, 2026, 1:35 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -61.81M | -69.71M | -63.02M | -70.69M | -56.05M | -40.56M | -45.6M | -36.11M | -24.76M | -13.98M | -7.44M | -11.62M | -12.35M | -12.22M | -16.47M | -14.74M | -12.12M | -15.88M | -14.32M | -6.29M | -32.69M | -76.29K |
Depreciation & Amortization | 896K | 845K | 751K | 745K | 742K | 378K | 1.3M | -586.56K | 342K | 328K | 3.29K | 3.29K | 3.29K | 3.29K | 3.29K | 3.29K | 3.29K | 2.49K | 2.49K | 2.27K | n/a | n/a |
Stock-Based Compensation | 2.55M | 13.36M | 3.59M | 3.71M | 3.31M | 2.29M | 1.93M | 1.84M | 1.83M | 1.68M | 1.61M | 1.43M | 1.5M | 2.58M | 2.6M | 2.59M | 2.48M | 1.99M | 7.76M | 1.86M | 1.25M | n/a |
Other Working Capital | 9.92M | -10.32M | -223K | 22.04M | -769K | -223K | -3.46M | 9.01M | -5.14M | -2.41M | -6.2M | 1.11M | -1.02M | 729.86K | 1.74M | 2.75M | -8.22M | 53.66K | 1M | 2.31M | 1.24M | -13.69K |
Other Non-Cash Items | 28K | 433K | 252K | 265K | -1.34M | 120K | -269.75K | 1.3M | 19K | -133K | -16.07K | -46.99K | -33.28K | 45.54K | 150.3K | 49.89K | -13.81M | 81.96K | 5.86M | 155.63K | 31.44M | -17.82K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 37.47K | -23.96K | -13.51K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 2.78M | -11.21M | -369K | 21.43M | -1.19M | -369K | -3.9M | 8.28M | -5.32M | -2.85M | -6.54M | 1.01M | -1.26M | 568.55K | 2.12M | 2.75M | -8.22M | -379.14K | 1M | 2.26M | 1.24M | -13.69K |
Operating Cash Flow | -55.56M | -66.29M | -58.79M | -44.54M | -54.53M | -38.14M | -48.47M | -25.28M | -27.89M | -14.95M | -12.34M | -9.25M | -12.16M | -9.02M | -11.6M | -9.35M | -34.15M | -14.19M | -7.45M | -2.02M | 6.14K | -107.8K |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | -35K | -175.57K | -131.95K | n/a | -212K | -284.63K | n/a | n/a | n/a | -1 | n/a | -16.01K | -16.01K | -18.37K | -11.65K | n/a | -5 |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -58.75M | -59.07M | -59.17M | n/a | -117.66M | -88.55M | -146.94M | -29.18M | -86.44M | -87.71M | -175.56B | -175.73M | n/a | n/a | 1 | -42.23M | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 59.07M | 59.17M | 29.26M | 88.4M | 205.91M | 144.83M | -211.05K | 87.59M | -1.3M | 59.12M | 117.15M | 1.36M | 12.68M | 19.65M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 175.56B | -174.38K | 12.68K | 19.65K | 9.9M | -42.23K | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 322K | 98K | -29.91M | 88.4M | 88.25M | 56.25M | -147.33M | 58.28M | -87.74M | -28.8M | 116.87M | -174.38M | 12.68M | 19.65M | 9.9M | -42.23M | -16.01K | -16.01K | -18.38K | -11.65K | -20.68K | n/a |
Debt Repayment | n/a | 24.47M | n/a | n/a | n/a | 73.02M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -15.15M | 15M | 15M | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -6.2K | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | 480K | n/a | n/a | n/a | 182.86K | n/a | -1.56M | -2.75M | n/a | n/a | n/a | 3.79K | n/a | -101M | 3.79K | -3.28K | 3.28K | n/a | -58.06K |
Financial Cash Flow | 234.62M | 30.64M | 72.4M | 480K | n/a | 73.12M | 150.71K | 183K | n/a | 50.98M | 28.42M | n/a | 451.29M | n/a | 3.79K | n/a | 18.54M | 15M | 15M | 498.33K | 27.82M | -58.06K |
Net Cash Flow | 179.42M | -36.03M | -16.22M | 44.06M | 35.12M | 91.14M | -195.23M | 32.87M | -115.65M | 7.27M | 133M | -183.62M | 451.66M | 10.62M | -1.7M | -51.5M | -8.32M | 795.31K | 7.01M | -1.53M | 6.14K | -165.86K |
Free Cash Flow | -55.56M | -66.29M | -58.79M | -44.54M | -54.53M | -38.18M | -48.65M | -25.41M | -27.89M | -15.16M | -12.63M | -9.25M | -12.16M | -9.02M | -11.6M | -9.35M | -34.17M | -14.2M | -7.47M | -2.03M | 6.14K | -107.8K |
Adj. Free Cash Flow | -58.1M | -79.64M | -62.38M | -48.25M | -57.84M | -40.47M | -50.58M | -27.25M | -29.72M | -16.84M | -14.23M | -10.68M | -13.66M | -11.6M | -14.19M | -11.94M | -36.65M | -16.19M | -15.23M | -3.89M | -1.24M | -107.8K |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | -35K | -175.57K | -131.95K | n/a | -212K | -3.29K | n/a | n/a | n/a | -1 | n/a | -3.29K | -2.49K | -2.49K | -2.27K | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -281.35K | n/a | n/a | n/a | n/a | n/a | -12.72K | -13.52K | -15.89K | -9.38K | n/a | -5 |
Owner Earnings | -55.56M | -66.29M | -58.79M | -44.54M | -54.53M | -38.18M | -48.65M | -25.41M | -27.89M | -15.16M | -12.35M | -9.25M | -12.16M | -9.02M | -11.6M | -9.35M | -34.16M | -14.19M | -7.45M | -2.02M | 6.14K | -107.8K |
Add to Watchlist
Select watchlists to add or remove MLTX